On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and innovative treatment options for familial hypercholesterolemia, sharing ...
SHANGHAI, April 2, 2024 /PRNewswire/ -- YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being developed as a single ...
Please provide your email address to receive an email when new articles are posted on . Familial hypercholesterolemia is underdiagnosed and undertreated. A novel machine learning algorithm identified ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results